These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 17256452)

  • 41. Effect of oral administration of fennel (Foeniculum vulgare) on ciprofloxacin absorption and disposition in the rat.
    Zhu M; Wong PY; Li RC
    J Pharm Pharmacol; 1999 Dec; 51(12):1391-6. PubMed ID: 10678493
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacokinetics of gatifloxacin in broiler chickens following intravenous and oral administration.
    Devada SS; Patel SD; Patel HB; Patel NN; Bhavsar SK; Thaker AM
    Br Poult Sci; 2012; 53(2):257-61. PubMed ID: 22646791
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lack of interaction between valaciclovir, the L-valyl ester of acyclovir, and Maalox antacid.
    de Bony F; Bidault R; Peck R; Posner J
    J Antimicrob Chemother; 1996 Feb; 37(2):383-7. PubMed ID: 8707752
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Interactions of fluoroquinolones with other drugs: mechanisms, variability, clinical significance, and management.
    Radandt JM; Marchbanks CR; Dudley MN
    Clin Infect Dis; 1992 Jan; 14(1):272-84. PubMed ID: 1571442
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Interaction of norfloxacin with divalent and trivalent pharmaceutical cations. In vitro complexation and in vivo pharmacokinetic studies in the dog.
    Wallis SC; Charles BG; Gahan LR; Filippich LJ; Bredhauer MG; Duckworth PA
    J Pharm Sci; 1996 Aug; 85(8):803-9. PubMed ID: 8863267
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Norfloxacin and absorption of magnesium-aluminum.
    Noyes M; Polk RE
    Ann Intern Med; 1988 Jul; 109(2):168-9. PubMed ID: 3382110
    [No Abstract]   [Full Text] [Related]  

  • 47. Drug interactions with quinolones.
    Janknegt R
    J Antimicrob Chemother; 1990 Nov; 26 Suppl D():7-29. PubMed ID: 2286594
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lack of effect of omeprazole or of an aluminium hydroxide/magnesium hydroxide antacid on the pharmacokinetics of lumiracoxib.
    Scott G; Vinluan Reynolds C; Milosavljev S; Langholff W; Shenouda M; Rordorf C
    Clin Pharmacokinet; 2004; 43(5):341-8. PubMed ID: 15080766
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacokinetics of the quinolones in volunteers: a proposed dosing schedule.
    Wise R; Griggs D; Andrews JM
    Rev Infect Dis; 1988; 10 Suppl 1():S83-9. PubMed ID: 3162327
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of sucralfate on the oral bioavailability of moxifloxacin, a novel 8-methoxyfluoroquinolone, in healthy volunteers.
    Stass H; Schühly U; Möller JG; Delesen H
    Clin Pharmacokinet; 2001; 40 Suppl 1():49-55. PubMed ID: 11352442
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of sucralfate on absorption of norfloxacin and ofloxacin.
    Lehto P; Kivistö KT
    Antimicrob Agents Chemother; 1994 Feb; 38(2):248-51. PubMed ID: 8192452
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Drug-drug interactions with ciprofloxacin and other fluoroquinolones.
    Polk RE
    Am J Med; 1989 Nov; 87(5A):76S-81S. PubMed ID: 2686430
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bile salt binding by maalox, sucralfate, and meciadanol: in vitro and clinical comparisons.
    Lipsett P; Gadacz TR
    J Surg Res; 1989 Nov; 47(5):403-6. PubMed ID: 2682004
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of vitreous levels of gatifloxacin after systemic administration in inflamed and non-inflamed eyes.
    Rajpal ; Srinivas A; Azad RV; Sharma YR; Kumar A; Satpathy G; Velpandian T
    Acta Ophthalmol; 2009 Sep; 87(6):648-52. PubMed ID: 19508273
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Quinolone pharmacokinetics and metabolism.
    Lode H; Höffken G; Boeckk M; Deppermann N; Borner K; Koeppe P
    J Antimicrob Chemother; 1990 Oct; 26 Suppl B():41-9. PubMed ID: 2124212
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bioavailability of gatifloxacin by gastric tube administration with and without concomitant enteral feeding in critically ill patients.
    Kanji S; McKinnon PS; Barletta JF; Kruse JA; Devlin JW
    Crit Care Med; 2003 May; 31(5):1347-52. PubMed ID: 12771601
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Urinary bactericidal activity, urinary excretion and plasma concentrations of gatifloxacin (400 mg) versus ciprofloxacin (500 mg) in healthy volunteers after a single oral dose.
    Boy D; Well M; Kinzig-Schippers M; Sörgel F; Ankel-Fuchs D; Naber KG
    Int J Antimicrob Agents; 2004 Mar; 23 Suppl 1():S6-16. PubMed ID: 15037323
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [The proper use of quinolones to the elderly patient with community-acquired pneumonia examined by Monte Carlo simulation].
    Yanagihara K; Morinaga Y; Fukushima K; Nakamura S; Kurihara S; Seki M; Izumikawa K; Kakeya H; Yamamoto Y; Miyazaki Y; Hirakata Y; Tashiro T; Kohno S
    Jpn J Antibiot; 2007 Oct; 60(5):251-6. PubMed ID: 18198653
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of antacids and ranitidine on the single-dose pharmacokinetics of fosamprenavir.
    Ford SL; Wire MB; Lou Y; Baker KL; Stein DS
    Antimicrob Agents Chemother; 2005 Jan; 49(1):467-9. PubMed ID: 15616339
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Minimal interaction between gatifloxacin and oxycodone.
    Grant EM; Nicolau DR; Nightingale C; Quintiliani R
    J Clin Pharmacol; 2002 Aug; 42(8):928-32. PubMed ID: 12162476
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.